Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Finasteride does not prevent bladder cancer.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.